Return
Genetic Modification of Limbal Stem Cells to Decrease Allogeneic Immune Responses
DOI:10.3389/fimmu.2021.747357.png)
Abstract
En 中文
Limbal stem cell (LSC) transplantation is the only efficient treatment for patients affected by LSC deficiency (LSCD). Allogeneic LSC transplantation is one of the most successful alternative for patients with bilateral LSCD. Nevertheless, the high variability of the human leukocyte antigens (HLA) remains a relevant obstacle to long-term allogeneic graft survival. This study characterized the immunologic properties of LSCs and proposed a genetic engineering strategy to reduce the immunogenicity of LSCs and of their derivatives. Hence, LSC HLA expression was silenced using lentiviral vectors encoding for short hairpin (sh) RNAs targeting beta 2-microglobulin (beta 2M) or class II major histocompatibility complex transactivator (CIITA) to silence HLA class I and II respectively. Beside the constitutive expression of HLA class I, LSCs showed the capability to upregulate HLA class II expression under inflammatory conditions. Furthermore, LSCs demonstrated the capability to induce T-cell mediated immune responses. LSCs phenotypical and functional characteristics are not disturbed after genetic modification. However, HLA silenced LSC showed to prevent T cell activation, proliferation and cytotoxicity in comparison to fully HLA-expressing LSCs. Additionally; HLA-silenced LSCs were protected against antibody-mediated cellular-dependent cytotoxicity. Our data is a proof-of-concept of the feasibility to generate low immunogenic human LSCs without affecting their typical features. The use of low immunogenic LSCs may support for long-term survival of LSCs and their derivatives after allogeneic transplantation.
Keywords:
limbal stem cell
RNA interference
HLA
limbal stem cell deficiency
allotransplantation
lentiviral vector
gene therapy
Journal
IF:
5.9
Papers:
5.3W
Citations:
29.8W
Organization
No organization information available
Cited Papers
Development of Dual-Aptamers for Constructing Sandwich-Type Pancreatic Polypeptide Assay
ACS Sensors
IF0
Systemic immunosuppression in limbal stem cell transplantation: best practices and future challenges

